NCT01509209View on ClinicalTrials.gov

Efficacy/Safety of Pseudoephedrine Plus Levocetirizine Versus Placebo in Patients With Vasomotor Rhinitis

PHASE3CompletedINTERVENTIONAL
Enrollment

137

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Vasomotor Rhinitis
Interventions
DRUG

Pseudoephedrine / Levocetirizine

tablet, BID everyday

Trial Locations (1)

156-707

ear, nose and throat, Boramae Hospital, Dongjak

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT01509209 - Efficacy/Safety of Pseudoephedrine Plus Levocetirizine Versus Placebo in Patients With Vasomotor Rhinitis | Biotech Hunter | Biotech Hunter